S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
NASDAQ:ATEC

Alphatec (ATEC) Stock Forecast, Price & News

$12.77
+0.35 (+2.82%)
(As of 09/22/2023 ET)
Compare
Today's Range
$12.38
$12.80
50-Day Range
$12.42
$18.72
52-Week Range
$7.68
$19.14
Volume
1.29 million shs
Average Volume
1.11 million shs
Market Capitalization
$1.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00

Alphatec MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
72.3% Upside
$22.00 Price Target
Short Interest
Bearish
8.41% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
-0.01mentions of Alphatec in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$1.99 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.39) to ($0.93) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.68 out of 5 stars

Medical Sector

108th out of 968 stocks

Surgical & Medical Instruments Industry

15th out of 90 stocks


ATEC stock logo

About Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization. It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

ATEC Price History

ATEC Stock News Headlines

Alphatec Holdings, Inc. (NASDAQ:ATEC) CEO Sells $801,000.00 in Stock
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Alphatec CEO sells shares worth $2.42M - filing
Alphatec (NASDAQ:ATEC) Stock Price Down 4.8% on Insider Selling
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Alphatec Holdings (ATEC) Receives a Buy from H.C. Wainwright
Expert Ratings for Alphatec Holdings
Alphatec (NASDAQ: ATEC)
ATEC Alphatec Holdings, Inc.
Where Alphatec Holdings Stands With Analysts
See More Headlines
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Company Calendar

Last Earnings
8/03/2023
Today
9/23/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ATEC
CUSIP
02081G10
Employees
705
Year Founded
1990

Price Target and Rating

Average Stock Price Forecast
$22.00
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+72.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-152,150,000.00
Pretax Margin
-39.62%

Debt

Sales & Book Value

Annual Sales
$350.87 million
Book Value
($0.35) per share

Miscellaneous

Free Float
85,282,000
Market Cap
$1.54 billion
Optionable
Not Optionable
Beta
1.27

Social Links

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Patrick S. MilesMr. Patrick S. Miles (Age 57)
    Exec. Chairman, CEO & Pres
    Comp: $1.59M
  • Mr. J. Todd Koning (Age 50)
    Exec. VP & CFO
    Comp: $815.29k
  • Mr. David P. SponselMr. David P. Sponsel (Age 44)
    Exec. VP of Sales
    Comp: $848.19k
  • Mr. Craig E. HunsakerMr. Craig E. Hunsaker (Age 59)
    Exec. VP of People and Culture
    Comp: $909.33k
  • Mr. Eric Dasso (Age 50)
    Exec. VP of Adjunctive Technologies
    Comp: $1M
  • Mr. Tyson Eliot Marshall (Age 49)
    Gen. Counsel & Corp. Sec.
  • Mr. Ali Shorooghi (Age 37)
    Sr. VP of Marketing
  • Mr. Jonathan Allen (Age 63)
    Exec. VP of Commercial Operations
  • Mr. Scott LishMr. Scott Lish (Age 42)
    Sr. VP of R&D
  • Dr. Luiz Pimenta
    Chief Medical Officer













ATEC Stock - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings
or view top-rated stocks.

What is Alphatec's stock price forecast for 2023?

7 brokerages have issued 12 month price targets for Alphatec's shares. Their ATEC share price forecasts range from $12.00 to $32.00. On average, they predict the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 72.3% from the stock's current price.
View analysts price targets for ATEC
or view top-rated stocks among Wall Street analysts.

How have ATEC shares performed in 2023?

Alphatec's stock was trading at $12.35 at the beginning of the year. Since then, ATEC stock has increased by 3.4% and is now trading at $12.77.
View the best growth stocks for 2023 here
.

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our ATEC earnings forecast
.

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) released its quarterly earnings results on Thursday, August, 3rd. The medical technology company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.30) by $0.13. The medical technology company earned $116.92 million during the quarter, compared to analysts' expectations of $110.18 million.

What ETFs hold Alphatec's stock?
What guidance has Alphatec issued on next quarter's earnings?

Alphatec issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $462.00 million-$462.00 million, compared to the consensus revenue estimate of $451.05 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?
What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Driehaus Capital Management LLC (2.29%), State Street Corp (1.79%), Cerity Partners LLC (1.56%), Geode Capital Management LLC (1.36%), Nuveen Asset Management LLC (1.29%) and Nuveen Asset Management LLC (1.29%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jeffrey G Black, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal and Scott Lish.
View institutional ownership trends
.

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $12.77.

How much money does Alphatec make?

Alphatec (NASDAQ:ATEC) has a market capitalization of $1.54 billion and generates $350.87 million in revenue each year. The medical technology company earns $-152,150,000.00 in net income (profit) each year or ($1.51) on an earnings per share basis.

How many employees does Alphatec have?

The company employs 705 workers across the globe.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356.

This page (NASDAQ:ATEC) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -